Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.
Innovations in pharmaceutical Analytics Including Microscopy, Chromatography, Spectroscopy, Separation Technologies, Flow Cytometry, Microarrays and RAMAN Imaging
Droplet-based single-cell analysis systems provide an invaluable tool to accelerate research and development. Recent scientific advances enhance the applicability of these droplet-based systems to address the age-old problem of characterising, understanding and selecting cells
The pharmaceutical industry is seeking new ways to accelerate the drug development process, to generate both time and cost savings. How is nuclear magnetic resonance spectroscopy helping to improve the drug development sector?
Flow cytometry is a powerful technology in the emerging cell and gene therapies (CGT) field and plays a significant role in various stages in the adoptive cell therapies, but what are its advantages and limitations?
rAAV vectorology is being optimised to allow for highly specific expression and greater efficacy – how is this being achieved, and why is it so important?
Recent developments in gene therapy and the approval of mrna vaccines for treating diseases has seen the biopharmaceutical industry’s need for more well-characterised rna and oligonucleotides than ever before. How are more nucleic acid sequences being analysed by mass spectrometry (ms) through the development of new technologies, and how can innovations in software process data fully automate the workflow of the confirmation of oligonucleotide sequences based on intact ms/ms
IPT recently spoke with Xiaobo Wang at Agilent about what’s been driving demand for flow cytometry and where the technology might be heading
How are handheld Raman devices and process analysers helping to streamline Quality Control (QC) procedures and enable continuous manufacturing?
As technology within the analysis sphere continues to evolve, temperature control is becoming increasingly important for drug discovery and research
Innovations in cellular biochemistry are helping to bring better personalised medicine onto the market. How can trapped ion mass spectrometry (TIMS) support this moving forward?
What improvements could High Resolution Ion Mobility (HRIM) bring to separation ability, throughput and reproducibility, and researchers’ understanding of glycoprotein structures?
The ability to visualise in greater detail and with better accuracy can offer laboratories an array of benefits. What new developments are entering the industry, and how can they overcome obstacles to analysis?